When was Cepheid founded?

Cepheid was founded in 1996 and raised its 1st funding round 4 years after it was founded.

Where is Cepheid located?

Cepheid is headquartered in Sunnyvale, United States. It is registered at 9th Floor, Paras Twin Towers, Tower B Golf Course, Sec-54, Gurgaon, Gurugram, Haryana, India, 122002.

How many employees does Cepheid have?

As of Mar 31, 2026, the latest employee count at Cepheid is 4674.

Is Cepheid a funded company?

Cepheid is a funded company, having raised a total of $19.1M across 9 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Jan 21, 2000.

How much is Cepheid worth?

The last known valuation of Cepheid was $***** as of Sep 06, 2016.

When was the latest funding round of Cepheid?

Cepheid's latest funding was a $***** Grant (prize money) round on Jul 30, 2021, with participation from 1 investor.

What is the annual revenue of Cepheid?

Annual revenue of Cepheid is $539M as on Dec 31, 2015.

Where does Cepheid rank among its competitors?

Cepheid ranks 1st amongst 426 active competitors, of which 41 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Agilent, which secured $432K in Dec, 2023.

Who are the top competitors of Cepheid?

Cepheid's top competitors include Sartorius, Agilent and Beckman Coulter. Among them, Agilent secured the most recent funding round in December, 2023.

Cepheid - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Cepheid an acquired company?

Cepheid got acquired by Danaher on Sep 06, 2016.

Company Details

Developer of molecular diagnostic testing solutions. The company offers a wide range of tests segregated into three major categories Hospital-acquired infection, Critical Infectious diseases (multi-drug resistant TB (MDR-TB), influenza, RSV, and Enteroviral meningitis) Sexual Health, and Genetic Test (30 Minute Test for Genetic Risk of Thrombosis).

Website: www.cepheid.com/en-US.html
Social
Registered Address: 9th Floor, Paras Twin Towers, Tower B Golf Course, Sec-54, Gurgaon, Gurugram, Haryana, India, 122002

Key Metrics

Founded Year

1996

Location

Sunnyvale, United States

Stage

Acquired

Total Funding

$19.1M in 9 rounds

Latest Funding Round

Grant (prize money), Jul 30, 2021, $*****

Last Known Valuation

$***** as on Sep 06, 2016

Investors

CampVentures & 15 more

Ranked

1^st among 426 active competitors

Annual Revenue

$539M as on Dec 31, 2015

Employee Count

4,674 as on Mar 31, 2026

Investment & Acquisitions

OncoMark

Similar Companies

Sartorius & 491 more

Exit Details

Acquired by Danaher (Sep 06, 2016)

View Cepheid's full profile

Cepheid is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CEPHEID INDIA PRIVATE LIMITED CIN: U33110HR2013FTC099516 , India, Active	Aug 22, 2013	$85.2M (As on Mar 31, 2025)	-
Cepheid Denmark ApS CIN: 42493139 , Denmark, Active	Jun 24, 2021	-	-
CEPHEID CIN: 1037760 , United States, Active	Dec 26, 2021	$539M (As on Dec 31, 2015)	1479 (As on Dec 31, 2017)	-
Cepheid CIN: 17704416258 , United States, Active		-	-	-

Cepheid got acquired by Danaher on Sep 06, 2016 at an acquisition amount of $4B.

Click here to take a look at Cepheid's acquisition in detail

Cepheid has raised a total funding of $19.1M over 9 rounds. Its first funding round was on Jan 21, 2000. Its latest funding round was a Grant (prize money) round on Jul 30, 2021 for $*****. 1 investor participated in its latest round. Cepheid has 16 institutional investors.

Here is the list of recent funding rounds of Cepheid:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 30, 2021	8584824	Grant (prize money)	8178545	3096112	2611575	2003567
Sep 20, 2014	2792094	Grant (prize money)	6206912	7528851	8416851	USAID
Jan 28, 2013	1172225	Post IPO	1519795	5427777	5839644	5083123

Access funding benchmarks and valuations. Sign up today!

View details of Cepheid's funding rounds and investors

The founders of Cepheid is Steve Young. John Bishop is the CEO of Cepheid.

Here are the details of Cepheid's key team members:

Steve Young: Co-Founder of Cepheid and founder of 3 other companies, UDP Labs, GetMyHomesValue.com and BAM Labs.

View details of Cepheid's Founder profiles and Board Members

Cepheid's employee count trend

Cepheid has 4,674 employees as of Mar 26. Here is Cepheid's employee count trend over the years:

Uncover Cepheid's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cepheid include Sartorius, Agilent and Beckman Coulter. Here is the list of Top 10 competitors of Cepheid, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cepheid 1996, Sunnyvale (United States), Acquired	Developer of molecular diagnostic testing solutions	$19.1M	CampVentures, BOMI & 14 others	73/100
2nd	Sartorius 1870, Gottingen (Germany), Public	Developer of laboratory and biopharmaceutical equipment	-	Juno Investment Partners, Eiffel Investment Group ... & 2 others	71/100
3rd	Agilent 1995, Santa Clara (United States), Public	Developer of diversified instruments for scientific and laboratory management	-	Smile Incubator, JANA Partners & 6 others	67/100
4th	Beckman Coulter 1935, Brea (United States), Acquired	Provider of diagnostic instruments, automation systems, and related clinical information management tools	-	Public Health Emergency, Identity Partners ... & 4 others	66/100
5th	Esco Lifesciences 1978, Singapore (Singapore), Late Stage	Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools	$200M	Vivo Capital, Novo Holdings & 3 others	66/100
6th	Bruker 1960, United States, Public	Manufacturer of high-performance scientific instruments for life sciences	-	Essex Investment Management, Burrill and Company ... & 5 others	66/100
7th	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	65/100
8th	Day Zero Diagnostics 2016, Boston (United States), Series B	Developer of genome sequencing-based diagnostics for infectious diseases	$49M	Triventures, Sands Capital & 10 others	64/100
9th	Mesa Labs 1982, Lakewood (United States), Public	Life science tools and critical quality control solutions provider	-	Yonghua Capital	58/100
10th	Unchained Labs 2015, Pleasanton (United States), Acquired	Developer of multiplex protein stability platform for biologics	$111M	Canaan, Novo Holdings & 5 others	57/100